Broad Growth Lifts MetLife Q2 Earnings 20%; Board Authorizes New $3B Buyback
MET sits 44% above its 52-week low of $67.33.
Summary
MetLife reported Q2 2026 adjusted earnings per share of $2.43, a 20% increase, and announced a new $3.0 billion share repurchase authorization, underscoring strong business momentum and shareholder returns.
Key Events · Earnings and Guidance · MET
-
Adjusted EPS Jumps 20%
Driven by favorable underwriting and broad volume growth across all segments, adjusted earnings per share reached $2.43, up from $2.02 a year ago.
-
New $3.0B Buyback Authorization
Adding to the $1.7 billion already repurchased year-to-date through July 2026, the Board approved a new $3.0 billion share repurchase program.
-
Adjusted ROE Hits 17%
Reflecting strong profitability and capital efficiency, adjusted return on equity reached 17%, at the top of the company's 15-17% target range.
-
Revenue Growth Across the Board
Premiums, fees and other revenues rose 7% to $13.7 billion, while adjusted PFOs excluding pension risk transfers were up 5% to $13.0 billion.
Analysis · MET · Finance
A standout quarter saw adjusted EPS climb 20% to $2.43, fueled by strong underwriting and volume growth across every operating segment. Signaling confidence in sustained capital generation, the Board simultaneously approved a new $3.0 billion share repurchase authorization. With an adjusted ROE of 17%—at the top of the company's target range—and holding company cash of $3.4 billion, the results reinforce the New Frontier strategy's momentum. The stock is trading near its 52-week high, reflecting market recognition of the improving earnings power and capital return capacity.
At the time of this filing, MET was trading at $97.00 on NYSE in the Finance sector, with a market capitalization of approximately $61.9B. The 52-week trading range was $67.33 to $97.80. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.